Search for: "Watson v. Watson"
Results 801 - 820
of 1,500
Sorted by Relevance
|
Sort by Date
15 Mar 2019, 4:00 am
"As to considering hearsay evidence in an administrative hearing, the Appellate Division said that "hearsay is admissible as competent evidence in an administrative proceeding, and if sufficiently relevant and probative may constitute substantial evidence even if contradicted by live testimony on credibility grounds" [see Matter of Watson v New York State Justice Ctr. for the Protection of People with Special Needs, 152 AD3d 1025]. [read post]
15 Mar 2019, 4:00 am
"As to considering hearsay evidence in an administrative hearing, the Appellate Division said that "hearsay is admissible as competent evidence in an administrative proceeding, and if sufficiently relevant and probative may constitute substantial evidence even if contradicted by live testimony on credibility grounds" [see Matter of Watson v New York State Justice Ctr. for the Protection of People with Special Needs, 152 AD3d 1025]. [read post]
21 Sep 2016, 5:48 am
People v. [read post]
12 Jan 2015, 5:57 am
In Watson Electrical Construction Co. v. [read post]
12 Jan 2015, 5:57 am
In Watson Electrical Construction Co. v. [read post]
5 Oct 2020, 9:15 am
Maine In Jones v. [read post]
15 Feb 2021, 5:28 am
In Chica v. [read post]
17 Jun 2007, 4:46 am
See Watson v. [read post]
16 May 2016, 9:01 pm
In Utah v. [read post]
3 Mar 2009, 4:01 am
" The Circuit Court said that "neither the ADA nor the Rehabilitation Act requires employers to forgo a qualification standard "until a perceived threat becomes real or questionable behavior results in injuries," citing Watson v. [read post]
5 Jan 2011, 9:37 am
In Torkie-Tork v. [read post]
22 Nov 2016, 7:32 am
Watson. [read post]
22 Nov 2016, 7:32 am
Watson. [read post]
18 May 2014, 11:06 am
Watson v. [read post]
18 May 2014, 11:06 am
Watson v. [read post]
12 Oct 2011, 3:46 am
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog) Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification (Patent Docs) Exelon… [read post]
4 Jul 2015, 6:43 am
Watson. [read post]
4 Jan 2010, 11:31 am
Watson, Circuit court held a non-compete was over broad as it prohibited the employee from performing work that she may not have done for her original employer.Why the case mattered? [read post]
16 Nov 2010, 2:00 am
Aug. 21, 2008) (upholding dismissal of claim for conspiracy finding none of acts complained of constitute either an unlawful purpose or unlawful means); Watson’s Carpet and Floor Coverings, Inc. v. [read post]
23 Sep 2013, 5:52 pm
Dietz & Watson, 679 F.3d 1372, 1377 (Fed. [read post]
